CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0460
-0.0007 (-1.50%)
At close: Jan 20, 2026
CV Sciences Employees
As of December 31, 2024, CV Sciences had 49 total employees, including 47 full-time and 2 part-time employees. The number of employees increased by 6 or 13.95% compared to the previous year.
Employees
49
Change (1Y)
6
Growth (1Y)
13.95%
Revenue / Employee
$299,292
Profits / Employee
-$30,792
Market Cap
8.48M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 49 | 6 | 13.95% | 47 | 2 |
| Dec 31, 2023 | 43 | -1 | -2.27% | 42 | 1 |
| Dec 31, 2022 | 44 | -27 | -38.03% | 42 | 2 |
| Dec 31, 2021 | 71 | -25 | -26.04% | 69 | 2 |
| Dec 31, 2020 | 96 | -29 | -23.20% | 91 | 5 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
CV Sciences News
- 4 weeks ago - CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD - Accesswire
- 2 months ago - CV Sciences Inc (CVSI) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - GuruFocus
- 2 months ago - Q3 2025 CV Sciences Inc Earnings Call Transcript - GuruFocus
- 2 months ago - CV Sciences outlines new non-cannabinoid product launches in 2026 while adapting to regulatory changes - Seeking Alpha
- 2 months ago - CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 2 months ago - CV Sciences, Inc. Reports Third Quarter 2025 Financial Results - Accesswire
- 2 months ago - CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 - Accesswire
- 5 months ago - CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & ... - GuruFocus